Chinese Journal of Pharmacovigilance ›› 2012, Vol. 9 ›› Issue (1): 26-28.

• Orginal Article • Previous Articles     Next Articles

Vaccine Risk Management in China

WANG Ya-li, DONG Duo, DU Xiao-xi*   

  1. Center for Drug Reevaluation, SFDA, Beijing 100045, China
  • Received:2011-04-25 Online:2012-01-10 Published:2015-08-10

Abstract: Drug risk management is a process around drug safety, which including risk evaluation, risk control, risk review and risk communication, through premarketing study or postmarketing adverse drug reaction monitoring.Vaccine risk management is important, because vaccine is a special drug. In this paper, the situation and problems about adverse vaccine reaction monitoring in our country were analyzed. And the risk management in our country was researched referencing international best practices.

Key words: vaccine, risk management